ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
120.269,31
-0,67%
S&P 500
5.970,84
-1,11%
US Dollar vs BRL
6,19575
0,00%
Bitcoin
94.429,95
0,29%
Brent Oil
73,44
0,00%
As Melhores Corretoras Online
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. (MM) (PCYC)

  7. (MM) (PCYC) Notícias

PCYC

(MM) (PCYC)

(MM)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:PCYC
DataHoraFonteTítuloCódigoCompanhia
15/06/201516:02Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:PCYC(MM)
10/06/201513:51Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PCYC(MM)
05/06/201508:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:PCYC(MM)
01/06/201512:24Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PCYC(MM)
31/05/201510:05PR Newswire (US)Ibrutinib (IMBRUVICA®) Phase Ib/II Data Show Promise in Patients with Chronic Graft-Versus-Host-DiseaseNASDAQ:PCYC(MM)
30/05/201508:31PR Newswire (US)Phase III HELIOS Study Results Show Ibrutinib (IMBRUVICA®) Combination Therapy Significantly Increased Progression-Free Surv...NASDAQ:PCYC(MM)
28/05/201520:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCYC(MM)
28/05/201510:00PR Newswire (US)Ibrutinib (IMBRUVICA®) in Combination with Anti-PD-L1 Antibody (MEDI4736) Study Commences for Patients with Two Relapsed/Ref...NASDAQ:PCYC(MM)
26/05/201509:48Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PCYC(MM)
26/05/201509:48Edgar (US Regulatory)(25-NSE)NASDAQ:PCYC(MM)
26/05/201509:40Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:PCYC(MM)
26/05/201508:35Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PCYC(MM)
26/05/201508:10Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:PCYC(MM)
22/05/201509:04PR Newswire (US)European Medicines Agency Issues Positive Opinion, Recommends Full Approval of IMBRUVICA® (ibrutinib) to Treat Waldenstrom's...NASDAQ:PCYC(MM)
20/05/201511:06The Motley FoolSWOT Analysis of Gilead Sciences Inc. StockNASDAQ:PCYC(MM)
14/05/201509:58Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:PCYC(MM)
13/05/201518:21PR Newswire (US)New ibrutinib (IMBRUVICA®) Data to be Showcased at American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:PCYC(MM)
05/05/201518:56Dow Jones NewsAbbVie Wraps Up Large Debt Sale for Pharmacyclics DealNASDAQ:PCYC(MM)
05/05/201518:38Dow Jones NewsAbbVie Wraps Up Large Debt Sale For Pharmacyclics DealNASDAQ:PCYC(MM)
05/05/201515:40Dow Jones NewsAbbVie Launches Large Debt Sale for Pharmacyclics DealNASDAQ:PCYC(MM)
05/05/201510:38Analyst Ratings NetworkZacks Lowers Pharmacyclics to Hold (PCYC)NASDAQ:PCYC(MM)
04/05/201518:09Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PCYC(MM)
04/05/201511:27Analyst Ratings NetworkPharmacyclics Lifted to "Buy" at Zacks (PCYC)NASDAQ:PCYC(MM)
01/05/201519:58Dow Jones NewsAbbVie Extends Exchange Offer to Acquire PharmacyclicsNASDAQ:PCYC(MM)
01/05/201510:15PR Newswire (US)Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business UpdatesNASDAQ:PCYC(MM)
23/04/201515:44Dow Jones NewsAbbVie Profit Rises on Broad Sales Growth -- UpdateNASDAQ:PCYC(MM)
23/04/201514:12Dow Jones NewsAbbVie Profit Rises 4.3%NASDAQ:PCYC(MM)
23/04/201514:08Dow Jones NewsAbbVie Profit Rises 4.3% on Broad Sales GrowthNASDAQ:PCYC(MM)
23/04/201512:34The Motley FoolHumira Propels AbbVie Inc. to a Solid First QuarterNASDAQ:PCYC(MM)
20/04/201513:16Analyst Ratings NetworkBMO Capital Markets Reiterates "Positive" Rating for Pharmacyclics (PCYC)NASDAQ:PCYC(MM)
 Apresentando as notícias mais relevantes sobre:NASDAQ:PCYC

Seu Histórico Recente

BOV
RCSL4
RECRUSUL PN
BOV
FICT3
Fictor Alimentos ON
BOV
BRAV3
Brava Energia ON
BOV
PRIO3
PETRORIO ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
CVCB3
CVC BRASIL ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados